DAFNA Capital Management LLC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 31 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$232,000
-3.3%
250,0000.0%0.09%
-16.3%
Q1 2019$240,000
+19.4%
250,0000.0%0.10%
+4.0%
Q4 2018$201,000
-25.3%
250,0000.0%0.10%
-9.1%
Q3 2018$269,000
+3.1%
250,0000.0%0.11%
-9.8%
Q2 2018$261,000
+15.0%
250,0000.0%0.12%
+10.9%
Q1 2018$227,000250,0000.11%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 1,000,000$1,043,0003.84%
Lion Point Capital, LP 20,000,000$20,776,0001.87%
Redmile Group, LLC 25,000,000$26,083,0000.89%
LINDEN ADVISORS LP 27,000,000$28,151,0000.87%
PFM Health Sciences, LP 32,411,000$33,750,0000.53%
WOLVERINE ASSET MANAGEMENT LLC 30,655,000$32,023,0000.41%
SSI INVESTMENT MANAGEMENT LLC 4,000,000$4,155,0000.34%
Partner Investment Management, L.P. 361,000$376,0000.30%
Rock Springs Capital Management LP 5,000,000$5,207,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,250,000$4,453,0000.13%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders